Last updated: October 26, 2022
Sponsor: Signal Relief
Overall Status: Completed
Phase
N/A
Condition
Muscle Pain
Chronic Pain
Acute Pain
Treatment
N/AClinical Study ID
NCT05288114
Signal -01-21
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Male or female subject aged ≥ 18 years.
- Currently seeking treatment for chronic musculoskeletal pain management.
- Visual analog scale score > 4 at baseline.
- Willing to refrain from the use of prescription pain medications during studyparticipation.
- Able and willing to provide informed consent.
Exclusion
Exclusion Criteria:
- Receiving other investigational agents or on another clinical trial. 2. In emergentneed for pain management. 3. Acute injury requiring rapid intervention or treatment. 4. Thesubject is using prescription medications (e.g., celecoxib, codeine, oxycodone, prednisone,etc.) for pain management regularly or PRN.
- The subject is currently undergoing or planning to begin physical therapy. 6. Thesubject is planning to begin a new exercise routine. 7. Subject has implantable paindevice, pacemaker, defibrillator, or other neuromodulation implantable device 8. Known tobe pregnant.
Study Design
Total Participants: 44
Study Start date:
January 21, 2022
Estimated Completion Date:
September 29, 2022
Study Description
Connect with a study center
Valley of the Sun Institute for Pain Management
Scottsdale, Arizona 85254
United StatesSite Not Available
Helios Health
Sedona, Arizona 86336
United StatesSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.